Back to News
Market Impact: 0.25

CL Quantitative Stock Analysis

CLNDAQ
Company FundamentalsAnalyst InsightsCorporate EarningsCapital Returns (Dividends / Buybacks)
CL Quantitative Stock Analysis

Colgate-Palmolive (CL) received a 68% rating from Validea's Patient Investor model, which is based on Warren Buffett's strategy, falling short of the 80% threshold typically indicating investment interest. While the large-cap personal and household products company demonstrated strengths in earnings predictability, debt service, and free cash flow, its performance on Return on Equity and Return on Total Capital were notable weaknesses, preventing a stronger endorsement from this value-oriented framework.

Analysis

Colgate-Palmolive (CL) receives a mixed evaluation from Validea's Patient Investor model, which is structured on Warren Buffett's investment principles. The company scored 68%, falling below the 80% threshold that indicates a strategy's interest. The analysis reveals a dichotomy in the company's fundamentals: CL passes key tests for earnings predictability, debt service, free cash flow generation, use of retained earnings, and share repurchases, signaling operational stability and shareholder-friendly capital management. However, the company fails on two critical profitability metrics: Return on Equity (ROE) and Return on Total Capital (ROTC). These specific failures are significant detractors within the Buffett framework, suggesting that while the business is predictable and manages debt well, its ability to generate high returns on its capital base is currently subpar according to this model.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo

Market Sentiment

Overall Sentiment

mildly positive

Sentiment Score

0.30

Ticker Sentiment

CL0.40
NDAQ0.00

Key Decisions for Investors

  • Investors should view Colgate-Palmolive as a stable, defensive holding with predictable earnings, but recognize that its profitability, specifically Return on Equity and Return on Total Capital, fails to meet the criteria of a strict value-oriented framework.
  • For those considering a position, it is critical to monitor future earnings for significant improvements in ROE and ROTC, as these are the primary weaknesses flagging the stock in this fundamental analysis.
  • Given the pass on share repurchases and predictable cash flow, the stock may fit in income-oriented or low-volatility portfolios, but investors seeking strong capital appreciation based on high capital efficiency should exercise caution.